Effect of Patala kshara with tilataila and Trikantakadi guggulu in reduction of lower urinary tract symptoms secondary to Benign Prostatic Hyperplasia - A Comparative clinical trial - NI

Dr Subi N H0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•Patients with LUTS secondary to BPH and diagnosed by Transabdominal Ultrasound.
•BPH with IPSS score minimum 5.
•Patients who are willing to provide written informed consent

•Known cases of Prostatitis, Carcinoma Prostate and those who have undergone any surgery for Prostate.
•Known cases with complications of BPH like acute urinary retention, haematuria, hydronephrosis and renal insufficiency.
•Known cases of stricture of urethra, congenital contracture of bladder neck and bladder polyps and diverticula.
•BPH patients with severe cardiac disease, uncontrolled diabetes mellitus and immuno-compromised.
•Those who are contraindicated for the internal use of kshara.

发起方

Dr Subi N H